Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: May 27, 2011 (rev. 1)

Premium

Exosome Diagnostics, a developer of biofluid-based molecular diagnostic tests for personalized medicine, has selected John Quackenbush to serve on its scientific advisory board.

Quackenbush is professor of computational biology and bioinformatics at the Dana-Faber Cancer Institute. Currently, his research focuses include the identification of expression fingerprints and genomic alterations that are relevant to colon and breast tumor metastasis; the development of novel computational approaches for the interpretation of large-scale datasets; and methods for data integration to facilitate gene discovery.

He completed a PhD in theoretical physics followed by a two-year postdoctoral position in experimental particle physics and phenomenology both at the University of California, Los Angeles.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.